Clinical trials
Ulcer clinical trials
Below are recruiting ulcer clinical trials, each written for real people, not researchers. We’re tracking 548 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06528873RecruitingPhase 4
COMS light therapy for chronic leg ulcers
This study tests a special light therapy called COMS to help heal chronic leg ulcers. It is for people with venous leg ulcers or mixed ulcers also involving artery disease, and aims to see if the treatment improves wound closure.
GrazAges 18 years+ - NCT06581328RecruitingPhase 4
Study of vedolizumab for ulcerative colitis or Crohn's disease
This study tests the drug vedolizumab in adults with moderate to severe ulcerative colitis or Crohn's disease. It aims to see how well the medicine works in a community (non-hospital) setting.
Birmingham, AlabamaAges 18–80 - NCT06584617Recruiting
Berovenal gel for faster diabetic foot ulcer healing
This study tests Berovenal gel, a special wound dressing, to see if it helps heal chronic diabetic foot ulcers faster than standard care. You may be eligible if you have a diabetic foot ulcer that is not infected and meets specific size and duration criteria.
Kösching, EichstattAges 18–85 - NCT06595719Recruiting
Probiotics plus standard care for mild to moderate UC
This trial tests whether adding a multi-strain probiotic supplement to your usual care can help manage mild to moderate ulcerative colitis (UC). It lasts 12 weeks and requires you to stay on your current medications without changes.
Cheras, Kuala LumpurAges 18–90 - NCT06598241Recruiting
Bioactive glass fiber study for diabetic foot ulcers
This study tests a special glass fiber material (BBFGM) placed on diabetic foot ulcers to help them heal. It is for people with diabetes who have a foot wound that hasn't healed in 4 weeks to 2 years, is a certain size, and may involve deeper tissue or bone.
San Antonio, TexasAges 18–80 - NCT05287126RecruitingPhase 2
Etrasimod for teens with active ulcerative colitis
This trial tests whether etrasimod can improve ulcerative colitis (UC) symptoms in adolescents with moderate to severe, active disease. It may help reduce inflammation and disease activity, especially if current treatments aren’t working well enough.
Little Rock, ArkansasAges 12–17 - NCT06604273RecruitingPhase 2/Phase 3
Studying bowel scarring in ulcerative colitis with filgotinib
This trial tests if filgotinib can help reduce intestinal scarring in people with active ulcerative colitis. It aims to understand fibrosis and find better ways to monitor treatment.
Amsterdam, North HollandAges 18 years+ - NCT06609447RecruitingPhase 4
Probiotic with vedolizumab for moderate ulcerative colitis
This study tests whether adding a special probiotic (VSL#3) to vedolizumab helps people with moderate ulcerative colitis more than vedolizumab alone. You may qualify if you are already planning to start vedolizumab and haven't responded well enough to other treatments.
Beijing, Beijing MunicipalityAges 18–85 - NCT06618612Recruiting
Wound matrix for diabetic foot ulcers
This study tests if a special wound dressing (collagen matrix with antimicrobial) plus standard care helps diabetic foot ulcers heal better than standard care alone. It's for people with diabetes who have a foot sore that hasn't healed for at least 4 weeks.
Clevland, OhioAges 18 years+ - NCT06636656RecruitingPhase 2
Testing a new drug for ulcerative colitis after other treatments failed
This study tests a new medication called BI 3032950 for people with ulcerative colitis who have already tried other advanced treatments (biologics or targeted therapies) that didn't work well enough or caused problems. The goal is to see if the new drug is safe and helps control inflammation in the colon.
Scottsdale, ArizonaAges 18–80 - NCT06651281RecruitingPhase 3
Long-term safety and effectiveness of tulisokibart for Crohn's or colitis
This study gives tulisokibart to people who already took part in an earlier trial for Crohn's disease or ulcerative colitis and are still benefiting from it. The goal is to see how safe and effective the medicine is over a longer period.
Bristol, ConnecticutAges Any age - NCT06658002RecruitingPhase 3
Testing stronger eye drops for fungal eye infections
This trial tests if adding cyclosporine A to the standard natamycin eye drops can better treat fungal eye infections. It may help people with moderate vision loss from a fungal corneal infection.
San Francisco, CaliforniaAges 18 years+ - NCT06660693RecruitingPhase 3
Comparing rescue treatments for severe ulcerative colitis flare
This trial tests two different medicines, infliximab and upadacitinib, to see which works better for people with severe ulcerative colitis that hasn't improved after 3 days of IV steroids. The goal is to find the best rescue option to help you feel better and avoid surgery.
Hamilton, OntarioAges 18–64 - NCT06667752Recruiting
Antibacterial wound dressing for diabetic foot ulcers
This trial tests a new antibacterial wound dressing to see if it helps heal diabetic foot ulcers safely. It may be an option if your ulcer has been there for over 4 weeks and is not severely infected.
Tallinn, HarjuAges 18 years+ - NCT06691061Recruiting
Comparing advanced treatments for ulcerative colitis after anti-TNF therapy
This trial compares three types of medications (vedolizumab, ustekinumab, and JAK inhibitors) in people with ulcerative colitis who have already tried an anti-TNF drug but still have active disease. The goal is to see which treatment works best as a second option.
Mialn, ItalyAges 18 years+ - NCT06693310Recruiting
Stopping therapy safely in ulcerative colitis with no inflammation
This trial tests whether people with ulcerative colitis who have been in deep remission (no signs of active disease) can safely reduce or stop their current medication. It aims to find out if careful monitoring can keep them healthy without full-dose treatment.
Chicago, IllinoisAges 18–75 - NCT06694883Recruiting
Ulcerative colitis remission-recurrence study
This trial studies people with ulcerative colitis who are in a 'remission-recurrence' state, meaning their symptoms come and go. It aims to better understand this pattern and may help guide future treatments.
Dongcheng, Beijing MunicipalityAges Any age - NCT06709209Recruiting
AI tool for grading colitis during colonoscopy
This study uses a special AI system that analyzes images from a colonoscopy to help doctors better understand how active your ulcerative colitis is and predict how it might progress. If you are scheduled for a routine colonoscopy, this AI tool may help your doctor make more precise treatment decisions.
LeuvenAges 18–75 - NCT06721754Recruiting
Negative pressure therapy for diabetic foot ulcers
This study tests if a vacuum-like wound dressing (negative pressure wound therapy) helps heal diabetic foot ulcers after surgery. It may be a good fit if you have a foot ulcer needing surgery and are able to walk.
Oslo, NordbyhagenAges 18 years+ - NCT06754735RecruitingPhase 4
Oxygen therapy for chronic leg ulcers
This study tests a new device that delivers oxygen to the wound area (topical wound oxygen therapy) to help heal chronic leg ulcers caused by vein disease. It may help people who have not seen enough healing with compression therapy alone.
New York, New YorkAges 18 years+ - NCT06764615RecruitingPhase 2
Long-term study of TAK-279 for ulcerative colitis and Crohn's disease
This study is for people who already completed 52 weeks of treatment with TAK-279 for ulcerative colitis or Crohn's disease and saw improvement. It gives them the option to continue the medication long-term to see if the benefits last.
Glen Burnie, MarylandAges 18–75 - NCT06764706Recruiting
Risankizumab for moderate-to-severe ulcerative colitis
This study observes how well risankizumab works for people with moderate to severe ulcerative colitis who are already starting it as part of their regular care. It helps doctors learn more about the drug's real-world effects.
Heidelberg, Baden-WurttembergAges 18 years+ - NCT06767501Recruiting
Amnion graft for diabetic foot ulcers vs. standard care
This trial tests whether a special amnion membrane graft can help heal diabetic foot ulcers better than standard care alone. If you have a diabetic foot ulcer that hasn't healed after standard treatment, this study may offer a new option.
Roanoke, VirginiaAges 18 years+ - NCT06784323Recruiting
Anti-inflammatory diet for Americans with ulcerative colitis
This trial tests whether a tailored anti-inflammatory diet based on American foods can help people with mild to moderately active ulcerative colitis. You'll follow a special meal plan with foods like soup, smoothies, salmon, and avocado, and researchers will track your symptoms and inflammation.
Miami, FloridaAges 16–75
Hear when a new Ulcer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ulcer?
- Yes. Clin2 currently lists 548 recruiting ulcer studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ulcer trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ulcer trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.